<DOC>
	<DOCNO>NCT01943552</DOCNO>
	<brief_summary>This randomize , double-blind , placebo-controlled , parallel-group , multi-centre trial.The trial aim evaluate efficacy nebulized ipratropium bromide Chinese peri-operative patient COPD general anaesthesia .</brief_summary>
	<brief_title>Ipratropium Bromide Peri-Operative COPD</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Ipratropium</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<criteria>Inclusion criterion : All patient must sign informed consent . Male female patient age &gt; = 40 year &lt; = 80 year All patient must diagnose COPD must meet follow spirometric criterion : postbronchodilator force expiratory volume 1 second ( FEV1 ) &lt; 70 % forced vital capacity ( FVC ) Screening Visit ( Visit 1 ) . All patient relatively stable COPD ( i.e . COPD exacerbation within 4 week prior Screening Visit ) . All patient receive selective surgical procedure lobectomy right bilobectomy segmentectomy general anaesthesia , whilst estimate time surgical procedure last less 2 hour , estimate time general anaesthesia last less 3 hour longer 5 hour . Patients must able perform study relate procedure include technically acceptable pulmonary function test ( PFTs ) . Exclusion criterion : Patients need maintenance treatment bronchodilator ( include anticholinergic , ßagonists , xanthine ) . Patients recent history ( i.e . six month less ) myocardial infarction Patients unstable lifethreatening cardiac arrhythmia require intervention change drug therapy last year Patients symptomatic chronic heart failure ( i.e . New York Heart Association functional class IIIIV ) Known narrow angle glaucoma Patients prostatic hyperplasia bladder neck obstruction significant symptoms Patients history asthma , allergic rhinitis blood eosinophil count &gt; = 600 / mm3 ( 0.6×10^9/L ) . A repeat eosinophil count conduct patient</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>